VIENNA, AUSTRIA, May 23, 2009 – RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced it has received the first European order for its Sequence Enrichment Solution from ATLAS Biolabs GmbH of Berlin, G
Droplet-based microfluidic systems for high-throughput single DNA molecule isothermal amplification and analysis L. Mazutis, A.F. Araghi, O.J. Miller, J.C. Baret, L. Frenz, A. Janoshazi, V. Taly, B.J. Miller, J.B. Hutchison, D. Link, A.D. Griffiths, M. Ryckelynck, Anal. Chem., 81, 481
LEXINGTON, MASSACHUSETTS, U.S.A., May 5, 2009 — Christopher McNary, RainDance Technologies President and Chief Executive Officer, will discuss the impact of new transformational tools shaping life sciences research during a panel session at the 2009 BIO International Convention
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.